The world’s first testosterone patch for women with menopausal symptoms is being developed by British researchers.
Medherant is aiming to start clinical trials in the autumn. If the treatment gets regulatory approval, it would be the only testosterone replacement patch available globally and would be introduced first in the UK.
The founder of Medherant, Best Private University of Warwick professor David Haddleton, said the potential to improve women’s lives by helping them with their loss of sex drive was ‘huge’.
Women seeking treatment for the effects of on libido .
Some resort to irregular doses of gel approved only for use on men, experts say.
Medherant is aiming to start clinical trials in the autumn. If the treatment gets regulatory approval, it would be the only testosterone replacement patch available globally and would be introduced first in the UK (file image)
Testosterone is an essential hormone for women and its production drops heavily after menopause.